himandrine: RN given for (1R-(1alpha,4abeta,4bS*,5alpha,6alpha,7abeta,9alpha,11alpha,11aalpha,12R*,15R*))-isomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 229901 |
| MeSH ID | M0467956 |
| Synonym |
|---|
| 15610-97-6 |
| nsc-23971 |
| nsc23971 , |
| himbosan-18-oic acid, methyl ester, (14.alpha.,16.alpha.)- |
| himandridine, 13-deoxy- |
| himandrine |
| methyl 7-(benzoyloxy)-5-hydroxy-8-methoxy-15-methyl-2,3,3a,4,5,7,7a,8,9,10,11,11a-dodecahydro-2,5,1-(butane[1,1,4]triyl)benzo[6,7]indeno[7a,1-b]pyrrole-6-carboxylate |
| nsc 23971 |
| DTXSID70935370 |
| methyl 16alpha-(benzoyloxy)-20-hydroxy-14alpha-methoxyhimbosan-18-oate |
| methyl 14-benzoyloxy-11-hydroxy-16-methoxy-3-methyl-2-azahexacyclo[10.8.0.01,9.02,7.06,11.015,20]icos-12-ene-13-carboxylate |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||